A number of brokerages have recently issued reports on HUM. Raymond James Financial raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price for the company in a research note on Thursday, May 1st. Truist Financial lowered their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Piper Sandler lowered their target price on shares of Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research note on Thursday, July 31st. Wall Street Zen lowered shares of Humana from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Finally, Royal Bank Of Canada boosted their target price on shares of Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a research note on Thursday.